| Monoamine theories of depression: historical impact on biomedical research S Mulinari Journal of the History of the Neurosciences 21 (4), 366-392, 2012 | 156 | 2012 |
| Chronic obstructive pulmonary disease in Sweden: an intersectional multilevel analysis of individual heterogeneity and discriminatory accuracy SA Fisk, S Mulinari, M Wemrell, G Leckie, RP Vicente, J Merlo SSM-population health 4, 334-346, 2018 | 104 | 2018 |
| The tyranny of the averages and the indiscriminate use of risk factors in public health: the case of coronary heart disease J Merlo, S Mulinari, M Wemrell, SV Subramanian, B Hedblad SSM-population health 3, 684-698, 2017 | 85 | 2017 |
| Contemporary epidemiology: a review of critical discussions within the discipline and a call for further dialogue with social theory M Wemrell, J Merlo, S Mulinari, AC Hornborg Sociology Compass 10 (2), 153-171, 2016 | 83 | 2016 |
| Sunshine policies and murky shadows in Europe: disclosure of pharmaceutical industry payments to health professionals in nine European countries A Fabbri, A la Santos, S Mezinska, S Mulinari, B Mintzes International Journal of Health Policy and Management 7 (6), 504, 2018 | 81 | 2018 |
| Intersectionality and risk for ischemic heart disease in Sweden: Categorical and anti-categorical approaches M Wemrell, S Mulinari, J Merlo Social Science & Medicine 177, 213-222, 2017 | 81 | 2017 |
| Complaints, complainants, and rulings regarding drug promotion in the United Kingdom and Sweden 2004–2012: a quantitative and qualitative study of pharmaceutical industry self … AV Zetterqvist, J Merlo, S Mulinari PLoS medicine 12 (2), e1001785, 2015 | 68 | 2015 |
| DRhoGEF2 and Diaphanous Regulate Contractile Force during Segmental Groove Morphogenesis in the Drosophila Embryo S Mulinari, MP Barmchi, U Häcker Molecular biology of the cell 19 (5), 1883-1892, 2008 | 59 | 2008 |
| Exposing drug industry funding of UK patient organisations P Ozieranski, E Rickard, S Mulinari Bmj 365, 2019 | 58 | 2019 |
| Disclosure of payments by pharmaceutical companies to healthcare professionals in the UK: analysis of the Association of the British Pharmaceutical Industry’s Disclosure UK … S Mulinari, P Ozieranski BMJ open 8 (10), e023094, 2018 | 46 | 2018 |
| Pharmaceutical industry off-label promotion and self-regulation: a document analysis of off-label promotion rulings by the United Kingdom prescription medicines code of … A Vilhelmsson, C Davis, S Mulinari PLoS medicine 13 (1), e1001945, 2016 | 44 | 2016 |
| Misleading advertising for antidepressants in Sweden: a failure of pharmaceutical industry self-regulation AV Zetterqvist, S Mulinari PLOS one 8 (5), e62609, 2013 | 42 | 2013 |
| Analysis of pharmaceutical industry payments to UK health care organizations in 2015 P Ozieranski, M Csanadi, E Rickard, J Tchilingirian, S Mulinari JAMA Network Open 2 (6), e196253-e196253, 2019 | 37 | 2019 |
| Expression and regulation of Spätzle-processing enzyme in Drosophila S Mulinari, U Häcker, C Castillejo-López FEBS letters 580 (22), 5406-5410, 2006 | 36 | 2006 |
| Questioning the discriminatory accuracy of broad migrant categories in public health: self-rated health in Sweden S Mulinari, A Bredström, J Merlo The European journal of public health 25 (6), 911-917, 2015 | 35 | 2015 |
| Pharmaceutical industry self-regulation and non-transparency: country and company level analysis of payments to healthcare professionals in seven European countries S Mulinari, L Martinon, PA Jachiet, P Ozieranski Health Policy 125 (7), 915-922, 2021 | 34 | 2021 |
| An intersectional approach to multilevel analysis of individual heterogeneity (MAIH) and discriminatory accuracy M Wemrell, S Mulinari, J Merlo Soc Sci Med 178, 217-9, 2017 | 33 | 2017 |
| Two-thirds of survey respondents in southern Sweden used complementary or alternative medicine in 2015 M Wemrell, J Merlo, S Mulinari, AC Hornborg Complementary medicine research 24 (5), 302-309, 2017 | 32 | 2017 |
| Failure of responsive regulation? Pharmaceutical marketing, corporate impression management and off-label promotion of enzalutamide in Europe S Mulinari, C Davis, P Ozieranski Journal of White Collar and Corporate Crime 2 (2), 69-80, 2021 | 31 | 2021 |
| Unhealthy marketing of pharmaceutical products: An international public health concern S Mulinari Journal of Public Health Policy 37, 149-159, 2016 | 30 | 2016 |
Piotr OzieranskiReader in Sociology, Department of Social and Policy Sciences, University of Bath在 bath.ac.uk 的电子邮件经过验证
Piotr OzieranskiReader in Sociology, Department of Social and Policy Sciences, University of Bath在 bath.ac.uk 的电子邮件经过验证